Cite
Optimization of trial duration to predict long-term HbA1c change with therapy: A pharmacometrics simulation-based evaluation
MLA
Hanna Kunina, et al. “Optimization of Trial Duration to Predict Long-Term HbA1c Change with Therapy: A Pharmacometrics Simulation-Based Evaluation.” CPT: Pharmacometricssystems Pharmacology, vol. 11, no. 11, July 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....eb30a65d70657441ab2d25e26a25288c&authtype=sso&custid=ns315887.
APA
Hanna Kunina, Alex Al‐Mashat, Jenny Y. Chien, Parag Garhyan, & Maria C. Kjellsson. (2022). Optimization of trial duration to predict long-term HbA1c change with therapy: A pharmacometrics simulation-based evaluation. CPT: Pharmacometricssystems Pharmacology, 11(11).
Chicago
Hanna Kunina, Alex Al‐Mashat, Jenny Y. Chien, Parag Garhyan, and Maria C. Kjellsson. 2022. “Optimization of Trial Duration to Predict Long-Term HbA1c Change with Therapy: A Pharmacometrics Simulation-Based Evaluation.” CPT: Pharmacometricssystems Pharmacology 11 (11). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....eb30a65d70657441ab2d25e26a25288c&authtype=sso&custid=ns315887.